Holen Sie sich die Stockscreener-App
0.1882
0.00%
0.00
Schlusskurs vom Vortag:
$0.1882
Offen:
$0.19
24-Stunden-Volumen:
34,142
Relative Volume:
0.18
Marktkapitalisierung:
$7.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.31M
KGV:
-0.1968
EPS:
-0.9564
Netto-Cashflow:
$-7.46M
1W Leistung:
+0.27%
1M Leistung:
-6.79%
6M Leistung:
-47.62%
1J Leistung:
-82.41%
1-Tages-Spanne:
$0.18
$0.19
1-Wochen-Bereich:
$0.175
$0.194
52-Wochen-Spanne:
$0.174
$1.38
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
Firmenname
Coeptis Therapeutics Holdings Inc
Sektor
Branche
Telefon
724-934-6467
Adresse
105 BRADFORD ROAD, SUITE 420, WEXFORD
Coeptis Therapeutics Holdings Inc Aktie (COEP) Neueste Nachrichten
Coeptis Therapeutics progresses in cell therapy trials - Investing.com
Coeptis Therapeutics progresses in cell therapy trials - Investing.com India
Coeptis Therapeutics progresses in cell therapy trials By Investing.com - Investing.com UK
Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders - Nasdaq
Coeptis Therapeutics (NASDAQ:COEP) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - Defense World
Coeptis Therapeutics to Present at the Emerging Growth Conferenc - GuruFocus.com
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Growth in Short Interest - Defense World
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting - Longview News-Journal
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting - Longview News-Journal
Coeptis Therapeutics retracts financial statements due to errors - Investing.com
Daily Progress: Coeptis Therapeutics Holdings Inc (COEP) Drop -0.88, Closing at 0.20 - The Dwinnex
Holdings of Coeptis Therapeutics Holdings Inc (COEP) are aligned with the stars - SETE News
Riding the Waves: A Guide to Investing in COEP Stock - The InvestChronicle
Was anything negative for Coeptis Therapeutics Holdings Inc (COEP) stock last session? - US Post News
Market Insight: Coeptis Therapeutics Holdings Inc (COEP)’s Notable Drop, Closing at 0.24 - The Dwinnex
Critical Survey: Vir Biotechnology (NASDAQ:VIR) & Coeptis Therapeutics (NASDAQ:COEP) - Defense World
A Guide To The Risks Of Investing In Coeptis Therapeutics Holdings Inc (COEP) – Knox Daily - Knox Daily
LADENBURG THALM/SH SH Lowers Coeptis Therapeutics (NASDAQ:COEP) to Hold - Defense World
Coeptis Therapeutics Closes $4.3 Million Series A - citybiz
Coeptis Therapeutics Closes $4.3M Series A Funding - FinSMEs
Coeptis Therapeutics closes on $4.3 million Series APittsburgh Business Times - The Business Journals
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million Underwritten Offering - Quantisnow
Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering - Quantisnow
Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer - Quantisnow
Coeptis Therapeutics to Present at the Emerging Growth Conference - Quantisnow
Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for ... - Quantisnow
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering - PR Newswire
COEP’s Stochastic Averages Dip: Analyzing Coeptis Therapeutics Holdings Inc’s Stock Performance - The InvestChronicle
Coeptis Therapeutics Holdings Inc (COEP) presents a great opportunity, but the stock is slightly overvalued – US Post ... - US Post News
Coeptis Therapeutics Holdings Inc's latest rating changes from various analysts – Knox Daily - Knox Daily
Head to Head Analysis: DBV Technologies (NASDAQ:DBVT) & Coeptis Therapeutics (NASDAQ:COEP) - Defense World
Is Coeptis Therapeutics Holdings Inc (COEP) positioned for future growth? – Sete News - SETE News
Coeptis Therapeutics Holdings Inc (COEP) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting - Marketscreener.com
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting - PR Newswire
Coeptis Therapeutics Holdings Inc (COEP) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News
Market Momentum: Coeptis Therapeutics Holdings Inc (COEP) Registers a 10.19 Increase, Closing at 0.29 – DWinneX - The Dwinnex
The time has not yet come to remove your chips from the table: Coeptis Therapeutics Holdings Inc (COEP) – Sete News - SETE News
Financial Metrics Exploration: Understanding Coeptis Therapeutics Holdings Inc (COEP) Through Ratios – DWinneX - The Dwinnex
Coeptis Therapeutics Holdings Inc [COEP] stock for 1305 USD was acquired by DeSilva Tara – Knox Daily - Knox Daily
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 10.6% - Defense World
A Tale of Resilience: Coeptis Therapeutics Holdings Inc Amid Stock Market Turbulence - The InvestChronicle
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024 - Nasdaq
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024 - PR Newswire
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th ... - PR Newswire
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting - PR Newswire
Coeptis Therapeutics' Dave Mehalick on Making Cell Therapy Universally AccessibleInvestorNews - InvestorNews Inc.
Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 ... - InvestorNews Inc.
Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - PR Newswire
CERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News Summary - Benzinga
Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections - PR Newswire
Finanzdaten der Coeptis Therapeutics Holdings Inc-Aktie (COEP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Coeptis Therapeutics Holdings Inc-Aktie (COEP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DeSilva Tara | Director |
Jan 12 '24 |
Buy |
0.58 |
2,266 |
1,305 |
32,266 |
| Yerace Daniel Alexander | VP of Operations |
Jan 05 '24 |
Buy |
0.69 |
10,850 |
7,486 |
1,071,455 |
| Salkind Gene | Director |
Jan 05 '24 |
Buy |
0.69 |
11,600 |
8,004 |
284,056 |
| Mehalick David | CEO and President |
Jan 08 '24 |
Buy |
0.66 |
20,004 |
13,263 |
2,782,615 |
| Mehalick David | CEO and President |
Jan 05 '24 |
Buy |
0.69 |
5,050 |
3,484 |
2,762,611 |
| Cochran Christopher P. | Director |
Jan 05 '24 |
Buy |
0.77 |
7,000 |
5,390 |
37,000 |
1.26%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):